When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven? [Yahoo! Finance]
Immunic, Inc. (IMUX)
Company Research
Source: Yahoo! Finance
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. The company's loss has recently broadened since it announced a US$94m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$98m, moving it further away from breakeven. The most pressing concern for investors is Immunic's path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate. View our latest analysis for Immunic Consensus from 5 of the American Biotechs analysts is that Immunic is on the verge of breakeven. They expect the company to post a final loss in 2025, before turning a profit of US$45m in 2026. The company is therefore projected to breakeven around 2 years from now. In order to meet this breakeven date, we calculated
Show less
Read more
Impact Snapshot
Event Time:
IMUX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMUX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMUX alerts
High impacting Immunic, Inc. news events
Weekly update
A roundup of the hottest topics
IMUX
News
- Immunic to Participate in Industry and Scientific Conferences in June [Yahoo! Finance]Yahoo! Finance
- Immunic to Participate in Industry and Scientific Conferences in JunePR Newswire
- Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully [Yahoo! Finance]Yahoo! Finance
- Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
IMUX
Earnings
- 5/8/24 - Miss
IMUX
Sec Filings
- 6/13/24 - Form 8-K
- 6/12/24 - Form 4
- 6/12/24 - Form 4
- IMUX's page on the SEC website